A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引：20

作者：

GOTO, Y ^{[1
]}

HOTTA, N ^{[1
]}

SHIGETA, Y ^{[1
]}

SAKAMOTO, N ^{[1
]}

KITO, S ^{[1
]}

MATSUOKA, K ^{[1
]}

TAKAHASHI, A ^{[1
]}

KIKKAWA, R ^{[1
]}

SAKUMA, A ^{[1
]}

机构：

[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN

来源：

DIABETIC MEDICINE | 1993年 / 10卷 / 05期

关键词：

ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;

D O I：

10.1111/j.1464-5491.1993.tb00197.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S39 / S43

页数：5

共 50 条

[41] Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: A randomized, double-blind, placebo-controlled study (ADMIRE study)
Kamijima, Kunitoshi
Higuchi, Teruhiko
Ishigooka, Jun
Ohmori, Tetsuro
Ozaki, Norio
Kanba, Shigenobu
Kinoshita, Toshihiko
Koyama, Tsukasa
JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (03) : 899 - 905
[42] Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT) A Randomized, Double-Blind, Placebo-Controlled Trial
Vaclavik, Jan
Sedlak, Richard
Plachy, Martin
Navratil, Karel
Plasek, Jiri
Jarkovsky, Jiri
Vaclavik, Tomas
Husar, Roman
Kocianova, Eva
Taborsky, Milos
HYPERTENSION, 2011, 57 (06) : 1069 - U94
[43] Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double-blind placebo-controlled study in Japan
Sekiguchi, Kenji
Kohara, Nobuo
Baba, Masayuki
Komori, Tetsuo
Naito, Yutaka
Imai, Tomihiro
Satoh, Jo
Yamaguchi, Yasuyuki
Hamatani, Tatsuto
JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 466 - 474
[44] Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Morita, Akimichi
Choon, Siew Eng
Bachelez, Herve
Anadkat, Milan J.
Marrakchi, Slaheddine
Zheng, Min
Tsai, Tsen-Fang
Turki, Hamida
Hua, Harry
Rajeswari, Sushmita
Thoma, Christian
Burden, A. David
DERMATOLOGY AND THERAPY, 2023, 13 (01) : 347 - 359
[45] A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FIXED-DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER
Gommoll, Carl
Durgam, Suresh
Mathews, Maju
Forero, Giovanna
Nunez, Rene
Tang, Xiongwen
Thase, Michael E.
DEPRESSION AND ANXIETY, 2015, 32 (06) : 451 - 459
[46] A Pooled Analysis of Suicidality in Double-Blind, Placebo-Controlled Studies of Sertraline in Adults
Vanderburg, Douglas G.
Batzar, Evan
Fogel, Ilan
Kremer, Charlotte M. E.
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (05) : 674 - 683
[47] Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Akimichi Morita
Siew Eng Choon
Hervé Bachelez
Milan J. Anadkat
Slaheddine Marrakchi
Min Zheng
Tsen-Fang Tsai
Hamida Turki
Harry Hua
Sushmita Rajeswari
Christian Thoma
A. David Burden
Dermatology and Therapy, 2023, 13 : 347 - 359
[48] Golden plaster for pain therapy in patients with knee osteoarthritis: study protocol for a multicenter randomized, double-blind, placebo-controlled trial
Jin-Tao Liu
De-Zhi Tang
Xiao-Feng Li
Zhi-Gang Zhang
Wan-Bo Ji
Shuai Tao
Yong-Jun Wang
Hong Jiang
Trials, 14
[49] Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
Correll, Christoph U.
Skuban, Aleksandar
Hobart, Mary
Ouyang, John
Weiller, Emmanuelle
Weiss, Catherine
Kane, John M.
SCHIZOPHRENIA RESEARCH, 2016, 174 (1-3) : 82 - 92
[50] Lamotrigine high-dose tolerability and safety in patients with epilepsy: A double-blind, placebo-controlled, eleven-week study
Matsuo, F
Gay, P
Madsen, J
Tolman, KG
Rollins, DE
Risner, ME
Lai, AA
EPILEPSIA, 1996, 37 (09) : 857 - 862

← 1 2 3 4 5 →